Markets:

Overview

News

Currencies

International

Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

3.820 -0.010 (-0.26%)

Streaming Delayed Price Updated: 2:06 PM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Evolent Health (EVH) Q3 2022 Earnings Call Transcript ↗

November 02, 2022

EVH earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

What 7 Analyst Ratings Have To Say About Evolent Health ↗

October 12, 2022

Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for Evolent Health ↗

August 19, 2022

Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:

Via Benzinga

What 6 Analyst Ratings Have To Say About Evolent Health ↗

August 03, 2022

Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings:

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday ↗

November 01, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal ↗

June 29, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Can Biotech Stocks Continue Rallying In This Bear Market? ↗

October 31, 2022

Via Talk Markets

Privia Health Stock Receives IBD Stock Rating Upgrade ↗

October 03, 2022

On Monday, Privia Health stock saw an improvement in its IBD SmartSelect Composite Rating, upgrading to 96 from 94.

Via Investor's Business Daily

4 Analysts Have This to Say About Evolent Health ↗

June 21, 2022

Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:

Via Benzinga

Chicago Faith Leaders Plan Coordinated Sermons to Destigmatize Mental Health in Underserved Communities

September 30, 2022

From Evolent Health

Via Business Wire

Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)

September 15, 2022

Via Investor Brand Network

Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)

September 09, 2022

Via Investor Brand Network

Whither Small Caps After Fed’s Tough Talk? ↗

August 29, 2022

For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and...

Via Talk Markets

Veeva Systems Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold ↗

August 16, 2022

Veeva Systems stock reached a key technical milestone, with its Relative Strength Rating, rising to 81 on Tuesday, up from 66 the day before.

Via Investor's Business Daily

Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗

August 15, 2022

The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring...

Via Talk Markets

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗

August 05, 2022

The Nasdaq and small caps rose while the S&P 500 is hitting resistance.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 02, 2022

Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is...

Via Benzinga

Evolent Health Is In Buy Zone Ahead Of Earnings Announcement ↗

August 02, 2022

Medical cost management firm Evolent Health reports late Tuesday.

Via Investor's Business Daily

Evolent Health's Earnings: A Preview ↗

August 01, 2022

Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗

July 29, 2022

Via Benzinga

Amazon's Acquisition Of One Medical Rattles Health Care Stocks ↗

July 21, 2022

Amazon health care expansion plans, including its $3.9 billion acquisition of One Medical for about $3.9 billion, shook health care stocks.

Via Investor's Business Daily

Small Cap Biotechs Regain Momentum ↗

July 11, 2022

Smaller cap biotech stocks soared off from recent lows looking like a redux of early 2021 when prices were double that of current values.

Via Talk Markets

Simulations Plus Stock Scores Composite Rating Move Up To 96 ↗

July 06, 2022

The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating.

Via Investor's Business Daily

Bear Market Rally Lifts HealthCare Stocks Off Bottom ↗

June 22, 2022

Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.

Via Talk Markets

Privia Health Stock Among The Few That've Risen This Month ↗

June 13, 2022

Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume.

Via Investor's Business Daily

Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know ↗

May 09, 2022

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022 ↗

March 30, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.